SPIA
COGT icon

Steward Partners Investment Advisory’s Cogent Biosciences COGT Stock Holding History

Steward Partners Investment Advisory’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.9K Buy
2,179
+20
+0.9% +$739 ﹤0.01% 2478
2025
Q4 		$76.7K Buy
2,159
+300
+16% +$8.43K ﹤0.01% 2444
2025
Q3 		$26.7K Buy
+1,859
New +$22K ﹤0.01% 2946

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Steward Partners Investment Advisory's COGT Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Cogent Biosciences (COGT) stake by 0.93% in Q1 2026, buying an estimated $739 and bringing the position to 2,179 shares worth $83.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Steward Partners Investment Advisory first reported a position in COGT in Q3 2025 and has held it in 3 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Steward Partners Investment Advisory held 2,179 shares of Cogent Biosciences worth $83.9K as of Q1 2026.
  • Steward Partners Investment Advisory bought 20 Cogent Biosciences shares in Q1 2026, an estimated $739.
  • Cogent Biosciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2478 holding.
  • Steward Partners Investment Advisory first reported a position in Cogent Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.